Exchange: NASDAQ·Updated 06:15 AM EDT
RLMD logo

RLMDRelmada Therapeutics Inc

$4.81
$0.19
(3.80%)
Pre-Market
Prev Close $5.00
EarningsAug 6
Mkt Cap$549.62M
Vol25.00
Upcoming Earnings: Q2 '26

Reports: Aug 06After Hours

Estimated EPS

-$0.20

Estimated Rev

$0M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.20
--
--
N/A
Q1 '26
-$0.20
-$0.22
-9.81%
MISSED
Q4 '25
-$0.15
-$0.27
-81.67%
MISSED
Q3 '25
-$0.42
-$0.30
29.28%
BEAT
Q2 '25
-$0.46
-$0.30
34.78%
BEAT

Advertisement|Remove ads.